<DOC>
	<DOCNO>NCT01332344</DOCNO>
	<brief_summary>The objective study compare healthcare utilization cost asthma patient receive fluticasone propionate/salmeterol combination 100mcg/50mcg ( `` FSC 100/50 '' ) inhale corticosteriods typical clinical practice use retrospective observational cohort study design large manage care database .</brief_summary>
	<brief_title>Outcomes Patients Taking Fluticasone Propionate/Salmeterol Combination Other Inhaled Corticosteroids</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Subjects asthma determine ICD9 code asthma drug use least 12 year age treat inhaled corticosteroid Subjects COPD treatment COPD</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>fluticasone propionate/salmeterol combination</keyword>
	<keyword>Asthma</keyword>
	<keyword>inhaled corticosteroid</keyword>
	<keyword>outcome</keyword>
</DOC>